Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-20-000742
Filing Date
2020-03-06
Accepted
2020-03-06 16:05:37
Documents
71
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 c95375_10q.htm 10-Q 557214
2 c95375_ex31-1.htm EX-31.1 7825
3 c95375_ex31-2.htm EX-31.2 8985
4 c95375_ex32-1.htm EX-32.1 3340
5 c95375_ex32-2.htm EX-32.2 3304
  Complete submission text file 0000930413-20-000742.txt   4239894

Data Files

Seq Description Document Type Size
6 enz-20200131.xml EX-101.INS 853919
7 enz-20200131.xsd EX-101.SCH 57961
8 enz-20200131_cal.xml EX-101.CAL 58925
9 enz-20200131_def.xml EX-101.DEF 260958
10 enz-20200131_lab.xml EX-101.LAB 439840
11 enz-20200131_pre.xml EX-101.PRE 263432
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 20694770
SIC: 8071 Services-Medical Laboratories